Archive for the
‘Allgemein’ Category

Confo Therapeutics appoints Dr. Cedric Ververken as Chief Executive Officer   Brussels, September 7, 2016 [09:00 CET] – Confo Therapeutics, an emerging drug discovery company, announces the appointment of Cedric Ververken as CEO and board member, starting October 1. Dr. Ververken will lead the transition of Confo Therapeutics from a technology company to a drug […]

7. September 2016

|

by: confo

|

Categories: Allgemein, Press Releases, ARCHIVE

Confo Therapeutics appoints Dr Christel Menet as Chief Scientific Officer Brussels, May 10, 2016 [09:00 CET] – Confo Therapeutics, an emerging drug discovery company, announced today that Dr Christel Menet is joining the company as Chief Scientific Officer, effective now. Dr. Menet will lead the research activities and build Confo Therapeutics’ pipeline of development programs […]

10. May 2016

|

by: confo

|

Categories: Allgemein, Press Releases, ARCHIVE

Confo Therapeutics secures €6.7 million in first financing round Investment will support first-in-class development programs for pathway selective drugs targeting GPCRs Brussels, Tuesday 02 February, 2016 [09:00 GMT] – Confo Therapeutics, an emerging drug discovery company, announced today the completion of its first financing round at €6.7 million. Incorporated in June 2015 by VIB and […]

2. February 2016

|

by: confo

|

Categories: Allgemein, Press Releases, ARCHIVE

By continuing to use the site, you agree to the use of cookies. more information

The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.

Close